{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:09:02Z","timestamp":1789589342584,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.actbio.2026.07.057","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T07:16:15Z","timestamp":1785482175000},"page":"476-487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Golden vesicular nanoadjuvant-loaded injectable hydrogel for locoregional photothermal-immunotherapy of unresectable glioblastoma"],"prefix":"10.1016","volume":"222","author":[{"given":"Songsong","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4928-8183","authenticated-orcid":false,"given":"Wenhai","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8608-7738","authenticated-orcid":false,"given":"Fenghua","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2026.07.057_bib0001","first-page":"1","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2017-2021","volume":"26","author":"Price","year":"2024","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.actbio.2026.07.057_bib0002","article-title":"Glioblastoma: clinical presentation, diagnosis, and management","volume":"374","author":"McKinnon","year":"2021","journal-title":"Br. Med. J."},{"issue":"4","key":"10.1016\/j.actbio.2026.07.057_bib0003","first-page":"299","article-title":"Management of glioblastoma: state of the art and future directions","volume":"70","author":"Tan","year":"2020","journal-title":"CA Cancer J. Clin."},{"issue":"13","key":"10.1016\/j.actbio.2026.07.057_bib0004","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1056\/NEJMc1509660","article-title":"Combined Nivolumab and Ipilimumab or monotherapy in untreated melanoma REPLY","volume":"373","author":"Larkin","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.actbio.2026.07.057_bib0005","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jtho.2018.03.008","article-title":"Clinical features and management of acquired resistance to PD-1 axis inhibitors in 26 patients with advanced non-small cell lung cancer","volume":"13","author":"Gettinger","year":"2018","journal-title":"J. Thorac. Oncol."},{"issue":"5","key":"10.1016\/j.actbio.2026.07.057_bib0006","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/neuonc\/nox208","article-title":"Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143","volume":"20","author":"Omuro","year":"2018","journal-title":"Neuro Oncol."},{"issue":"7","key":"10.1016\/j.actbio.2026.07.057_bib0007","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.actbio.2026.07.057_bib0008","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41571-018-0003-5","article-title":"Current state of immunotherapy for glioblastoma","volume":"15","author":"Lim","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.actbio.2026.07.057_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2025.08.343","article-title":"P48-1 Gamma knife radiosurgery for recurrent glioblastoma: a systematic review of retrospective cohort","volume":"36","author":"Santoso","year":"2025","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.actbio.2026.07.057_bib0010","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1093\/neuonc\/noae247","article-title":"Phase 2 trial of veliparib, local irradiation, and temozolomide in patients with newly diagnosed high-grade glioma: a children's oncology group study","volume":"27","author":"Karajannis","year":"2025","journal-title":"Neuro Oncol."},{"issue":"11","key":"10.1016\/j.actbio.2026.07.057_bib0011","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.3390\/cancers16112131","article-title":"Safety and efficacy of laser interstitial thermal therapy as upfront therapy in primary glioblastoma and IDH-mutant astrocytoma: a meta-analysis","volume":"16","author":"Pandey","year":"2024","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.actbio.2026.07.057_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuchi.2025.101629","article-title":"Synergistic effects of laser interstitial thermal therapy (LITT) and immunotherapy for brain tumor recurrence: a systematic review and meta-analysis","volume":"71","author":"Sharma","year":"2025","journal-title":"Neurochirurgie"},{"issue":"8","key":"10.1016\/j.actbio.2026.07.057_bib0013","first-page":"e26","article-title":"Efficacy and safety of Carmustine wafer implantation after ventricular opening in glioblastomas, isocitrate dehydrogenase-wildtype, in adults","volume":"94","author":"Roux","year":"2024","journal-title":"Neurosurgery"},{"issue":"3","key":"10.1016\/j.actbio.2026.07.057_bib0014","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11060-024-04679-2","article-title":"Clinical course after Carmustine wafer implantation for newly diagnosed adult-type diffuse gliomas; a controlled propensity matched analysis of a single center cohort","volume":"168","author":"Ono","year":"2024","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.actbio.2026.07.057_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113976","article-title":"Nano-golden adjuvant-polymersomes empower tumor photothermal-immunotherapy","volume":"385","author":"Sun","year":"2025","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.actbio.2026.07.057_bib0016","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1021\/acsnano.2c10094","article-title":"Penetrative and sustained drug delivery using injectable hydrogel nanocomposites for postsurgical brain tumor treatment","volume":"17","author":"Kang","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.actbio.2026.07.057_bib0017","first-page":"387","article-title":"A multifunctional injectable MPDA@MTIC\u2013Co hydrogel platform for synergistic chemotherapy\u2013photothermal therapy of postoperative glioblastoma","volume":"60","author":"Zhang","year":"2026","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.actbio.2026.07.057_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113842","article-title":"Sustained codelivery of heat shock protein peptide and rapamycin via nano-in-hydrogel induces immune tolerance in rheumatoid arthritis","volume":"383","author":"Cao","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2026.07.057_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122495","article-title":"Intraoperative application of intelligent, responsive, self-assembling hydrogel rectifies oxygen and energy metabolism in traumatically injured brain","volume":"306","author":"Han","year":"2024","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.actbio.2026.07.057_bib0020","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1158\/2767-9764.CRC-25-0414","article-title":"MicroCT enables simultaneous longitudinal tracking of murine pancreatic cancer progression and cachexia","volume":"5","author":"Pelz","year":"2025","journal-title":"Cancer Res. Commun."},{"issue":"18","key":"10.1016\/j.actbio.2026.07.057_bib0021","doi-asserted-by":"crossref","first-page":"10346","DOI":"10.1021\/acs.chemrev.5b00703","article-title":"Atomically precise colloidal metal nanoclusters and nanoparticles: fundamentals and opportunities","volume":"116","author":"Jin","year":"2016","journal-title":"Chem. Rev."},{"issue":"13","key":"10.1016\/j.actbio.2026.07.057_bib0022","doi-asserted-by":"crossref","DOI":"10.1063\/1.3575185","article-title":"Semiclassical approach to plasmon-electron coupling and Landau damping of surface plasmons","volume":"134","author":"Gao","year":"2011","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.actbio.2026.07.057_bib0023","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.actbio.2024.12.025","article-title":"Molecular design of ternary copolymers with high photothermal performance in the near-infrared window for effective treatment of gliomas in vivo","volume":"192","author":"Su","year":"2025","journal-title":"Acta Biomater."},{"issue":"23","key":"10.1016\/j.actbio.2026.07.057_bib0024","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202400784","article-title":"Polymersomal poly(I:C) self-magnifies antitumor immunity by inducing immunogenic cell death and systemic immune activation","volume":"13","author":"Wang","year":"2024","journal-title":"Adv. Healthc. Mater."},{"issue":"12","key":"10.1016\/j.actbio.2026.07.057_bib0025","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.actbio.2026.07.057_bib0026","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/s41590-019-0433-y","article-title":"Mechanisms of immunotherapy resistance: lessons from glioblastoma","volume":"20","author":"Jackson","year":"2019","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.actbio.2026.07.057_bib0027","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13045-020-00950-x","article-title":"HMGB1 in inflammation and cancer","volume":"13","author":"Wang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.actbio.2026.07.057_bib0028","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.2119\/molmed.2015.00087","article-title":"High mobility group Box protein 1 (HMGB1): the prototypical endogenous danger molecule","volume":"21","author":"Yang","year":"2015","journal-title":"Mol. Med."},{"issue":"1","key":"10.1016\/j.actbio.2026.07.057_bib0029","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12943-025-02491-8","article-title":"Therapeutic targeting of cell death-immune crosstalk in cancer to rewire the tumor immune microenvironment","volume":"24","author":"Zhang","year":"2025","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.actbio.2026.07.057_bib0030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/imr.12621","article-title":"Overview of the IL-1 family in innate inflammation and acquired immunity","volume":"281","author":"Dinarello","year":"2018","journal-title":"Immunol. Rev."},{"issue":"5633","key":"10.1016\/j.actbio.2026.07.057_bib0031","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1126\/science.1087262","article-title":"Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway","volume":"301","author":"Yamamoto","year":"2003","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.actbio.2026.07.057_bib0032","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.addr.2007.11.005","article-title":"TLR3:: Interferon induction by double-stranded RNA including poly(I:C)","volume":"60","author":"Matsumoto","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.actbio.2026.07.057_bib0033","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.immuni.2019.03.011","article-title":"The immunobiology of the interleukin-12 Family: room for discovery","volume":"50","author":"Wojno","year":"2019","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.actbio.2026.07.057_bib0034","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028431","article-title":"The Tumor Necrosis Factor Family: family conventions and private idiosyncrasies","volume":"10","author":"Wallach","year":"2018","journal-title":"Cold. Spring. Harb. Perspect. Biol."},{"issue":"2","key":"10.1016\/j.actbio.2026.07.057_bib0035","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028415","article-title":"Interleukin-6 Family cytokines","volume":"10","author":"Rose-John","year":"2018","journal-title":"Cold. Spring. Harb. Perspect. Biol."},{"issue":"5","key":"10.1016\/j.actbio.2026.07.057_bib0036","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.4049\/jimmunol.1502376","article-title":"Chemoattractant receptors BLT1 and CXCR3 regulate antitumor immunity by facilitating CD8+ T cell migration into tumors","volume":"197","author":"Chheda","year":"2016","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.actbio.2026.07.057_bib0037","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","article-title":"NK cells stimulate recruitment of cDC1 into the tumor microenvironment promoting cancer immune control","volume":"172","author":"Boettcher","year":"2018","journal-title":"Cell"},{"issue":"20","key":"10.1016\/j.actbio.2026.07.057_bib0038","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1182\/blood.2020006675","article-title":"CXCR4 signaling controls dendritic cell location and activation at steady state and in inflammation","volume":"137","author":"Gallego","year":"2021","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.actbio.2026.07.057_bib0039","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41467-024-44787-1","article-title":"Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity","volume":"15","author":"Lee","year":"2024","journal-title":"Nat. Commun."},{"issue":"33","key":"10.1016\/j.actbio.2026.07.057_bib0040","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202420630","article-title":"Intranasal and intravenous sequential administration of Survivin peptide-CpG Nanovaccines elicits potent immunity toward glioblastoma","volume":"37","author":"Shi","year":"2025","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.actbio.2026.07.057_bib0041","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1038\/s41467-024-46118-w","article-title":"Serum amyloid A promotes glycolysis of neutrophils during PD-1 blockade resistance in hepatocellular carcinoma","volume":"15","author":"He","year":"2024","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.actbio.2026.07.057_bib0042","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2023.02.014","article-title":"Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy","volume":"41","author":"Tay","year":"2023","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.actbio.2026.07.057_bib0043","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","article-title":"T cells in health and disease","volume":"8","author":"Sun","year":"2023","journal-title":"Signal. Transduct. Target. Ther."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126005040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126005040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:00:40Z","timestamp":1789588840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706126005040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":43,"alternative-id":["S1742706126005040"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2026.07.057","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Golden vesicular nanoadjuvant-loaded injectable hydrogel for locoregional photothermal-immunotherapy of unresectable glioblastoma","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2026.07.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Acta Materialia Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}